Inventor
SHERWOOD TREVOR C
US15 patents
Patents
15 patentsUS10071079B2Sep 11, 2018
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
BRISTOL MYERS SQUIBB CO6 citations84
US10912766B2Feb 9, 2021
[1,2,4]triazolo[1,5-A]pyridinyl substituted indole compounds
BRISTOL MYERS SQUIBB CO6 citations83
US11053244B1Jul 6, 2021
4-azaindole compounds
BRISTOL MYERS SQUIBB CO6 citations82
US10730877B2Aug 4, 2020
4-Azaindole compounds
BRISTOL MYERS SQUIBB CO6 citations82
USRE49880EMar 26, 2024
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
BRISTOL MYERS SQUIBB CO2 citations73
US11420973B2Aug 23, 2022
Amide substituted indole compounds useful as TLR inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US11130756B2Sep 28, 2021
[1,2,4]Triazolo[4,3-A]pyridinyl substituted indole compounds
BRISTOL MYERS SQUIBB CO6 citations72
USRE49893EApr 2, 2024
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
BRISTOL MYERS SQUIBB CO1 citations71
US12384760B2Aug 12, 2025
Substituted carbazole compounds
BRISTOL MYERS SQUIBB CO0 citations62
US11672780B2Jun 13, 2023
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
BRISTOL MYERS SQUIBB CO0 citations62
US11820768B2Nov 21, 2023
4-azaindole compounds
BRISTOL MYERS SQUIBB CO0 citations61
US11597721B2Mar 7, 2023
Heterocyclic compounds comprising pyridine useful as modulators of IL-12, IL-23 and/or IFNα responses
BRISTOL MYERS SQUIBB CO1 citations59
US12240840B2Mar 4, 2025
Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha
BRISTOL MYERS SQUIBB CO0 citations51
US11739098B2Aug 29, 2023
Substituted indole compounds
BRISTOL MYERS SQUIBB CO0 citations51
US11878975B2Jan 23, 2024
Substituted indole compounds useful as TLR inhibitors
BRISTOL MYERS SQUIBB CO0 citations50